Abbott Laboratories, a pharmaceutical and medical device company in Abbott Park, Ill., will pay $410 million in cash to acquire all outstanding shares of cardiac-device maker Evalve, Menlo Park, Calif., according to a news release. Abbott currently holds a 10% interest in the devicemaker.
Abbott to buy devicemaker Evalve
Evalve specializes in the development of catheter-based devices used to repair cardiac mitral valves. The deal, which is subject to customary regulatory review, is expected to close during the fourth quarter of 2009.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.